By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson reported after the close of the market Tuesday that its second-quarter revenues swelled 7 percent overall, driven in part by a 9 percent increase in its BD Diagnostics business year over year.

BD had total revenues of $1.92 billion for the three-month period ended March 31, compared to $1.8 billion for the second quarter of 2010. Analysts had expected the company to earn revenues of $1.86 billion for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: The sea anemone is sequenced, a team describes a CRISPR/Cas9-based approach to label specific sites in the genome, and more. 

In a short video, CNN introduces viewers to a fecal transplant poop donor and explains how the treatments are made.

Researchers are testing the use of transgenically altered diamondback moths as an alternative to pesticides in controlling the bugs.

Two recent papers published in Science and Nature Medicine describe work that may result in a universal vaccine for the flu.